3-((4-(4-(tert-Butyl)phenylsulfonamido)-7-chloro-1,3-dioxoisoindolin-2-yl)methyl)-pyridine 1-oxide

ID: ALA3799220

Chembl Id: CHEMBL3799220

PubChem CID: 118197423

Max Phase: Preclinical

Molecular Formula: C24H22ClN3O5S

Molecular Weight: 499.98

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc(Cl)c3c2C(=O)N(Cc2ccc[n+]([O-])c2)C3=O)cc1

Standard InChI:  InChI=1S/C24H22ClN3O5S/c1-24(2,3)16-6-8-17(9-7-16)34(32,33)26-19-11-10-18(25)20-21(19)23(30)28(22(20)29)14-15-5-4-12-27(31)13-15/h4-13,26H,14H2,1-3H3

Standard InChI Key:  NYFMBNUDUROXPI-UHFFFAOYSA-N

Associated Targets(Human)

Liver microsome (8277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCR9 Tchem C-C chemokine receptor type 9 (785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 499.98Molecular Weight (Monoisotopic): 499.0969AlogP: 3.87#Rotatable Bonds: 5
Polar Surface Area: 110.49Molecular Species: ACIDHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 4.86CX Basic pKa: 0.99CX LogP: 2.80CX LogD: 1.87
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.33Np Likeness Score: -1.49

References

1. Kalindjian SB, Kadnur SV, Hewson CA, Venkateshappa C, Juluri S, Kristam R, Kulkarni B, Mohammed Z, Saxena R, Viswanadhan VN, Aiyar J, McVey D..  (2016)  A New Series of Orally Bioavailable Chemokine Receptor 9 (CCR9) Antagonists; Possible Agents for the Treatment of Inflammatory Bowel Disease.,  59  (7): [PMID:26987013] [10.1021/acs.jmedchem.5b01840]

Source